[go: up one dir, main page]

AU2003231245A1 - Molecules for disease detection and treatment - Google Patents

Molecules for disease detection and treatment

Info

Publication number
AU2003231245A1
AU2003231245A1 AU2003231245A AU2003231245A AU2003231245A1 AU 2003231245 A1 AU2003231245 A1 AU 2003231245A1 AU 2003231245 A AU2003231245 A AU 2003231245A AU 2003231245 A AU2003231245 A AU 2003231245A AU 2003231245 A1 AU2003231245 A1 AU 2003231245A1
Authority
AU
Australia
Prior art keywords
molecules
treatment
disease detection
disease
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003231245A
Other versions
AU2003231245A8 (en
Inventor
Shanya D. Becha
Sean A. Bulloch
Hsin-Ru Chang
Narinder K. Chawla
Vicki S. Elliott
Ian J. Forsythe
Glenn K. Fu
Kimberly J. Gietzen
Jennifer A. Griffin
April J.A. Hafalia
Alan A. Jackson
Xin Jiang
Pei Jin
Amy E. Kable
Reena Khare
Soo Y. Lee
Joseph P. Marquis
Patricia M. Mason
Jayalaxmi Ramkumar
Thomas W. Richardson
Anita Swarnakar
Y. Tom Tang
Uyen K. Tran
Amy D. Wilson
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of AU2003231245A8 publication Critical patent/AU2003231245A8/en
Publication of AU2003231245A1 publication Critical patent/AU2003231245A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2003231245A 2002-04-30 2003-04-30 Molecules for disease detection and treatment Abandoned AU2003231245A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US37698802P 2002-04-30 2002-04-30
US60/376,988 2002-04-30
US38909502P 2002-06-14 2002-06-14
US60/389,095 2002-06-14
US40586002P 2002-08-22 2002-08-22
US60/405,860 2002-08-22
US40651202P 2002-08-27 2002-08-27
US60/406,512 2002-08-27
PCT/US2003/013629 WO2003093427A2 (en) 2002-04-30 2003-04-30 Molecules for disease detection and treatment

Publications (2)

Publication Number Publication Date
AU2003231245A8 AU2003231245A8 (en) 2003-11-17
AU2003231245A1 true AU2003231245A1 (en) 2003-11-17

Family

ID=29408062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003231245A Abandoned AU2003231245A1 (en) 2002-04-30 2003-04-30 Molecules for disease detection and treatment

Country Status (2)

Country Link
AU (1) AU2003231245A1 (en)
WO (1) WO2003093427A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121174A2 (en) * 2004-06-04 2005-12-22 Five Prime Therapeutics, Inc. Novel g-csf polypeptides, polynucleotides, modulators thereof, and methods of use
US8163482B2 (en) 2006-02-23 2012-04-24 Nicholas Katsanis BBS10 related diagnostic methods for Bardet-Biedl syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2329076A1 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase

Also Published As

Publication number Publication date
AU2003231245A8 (en) 2003-11-17
WO2003093427A3 (en) 2005-09-01
WO2003093427A2 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2002338265A1 (en) Molecules for disease detection and treatment
AU2003232485A1 (en) Neopeptides and methods useful for detection and treatment of cancer
EP1552002A4 (en) Aptamer-toxin molecules and methods for using same
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2002329784A1 (en) Molecules for disease detection and treatment
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2002364890A1 (en) Molecules for disease detection and treatment
AU2003205174A1 (en) Molecules for disease detection and treatment
AU2003268023A1 (en) Protein modification and maintenance molecules
AU2003205353A1 (en) Protein modification and maintenance molecules
AU2001241709A1 (en) Molecules for disease detection and treatment
AU2002243539A1 (en) Molecules for disease detection and treatment
AU2002347899A1 (en) Molecules for disease detection and treatment
AU2003231245A1 (en) Molecules for disease detection and treatment
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2002248723A1 (en) Molecules for disease detection and treatment
AU2002359567A1 (en) Molecules for disease detection and treatment
AU2003231981A1 (en) Protein modification and maintenance molecules
AU2002239543A1 (en) Molecules for disease detection and treatment
AU2003239871A1 (en) Protein modification and maintenance molecules
AU5319400A (en) Molecules for disease detection and treatment
AU2002320026A1 (en) Molecules for disease detection and treatment
EP1390410A4 (en) Molecules for disease detection and treatment
AU2002238070A1 (en) Molecules for disease detection and treatment
AU2002312075A1 (en) Molecules for disease detection and treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase